Formule à base de mélatonine et de mélisse
30 gélules T0 HPMC par pilulier
Ingredient | Dose per capsule | Dose per day | Specifications |
---|---|---|---|
Mélisse | NA | 100 mg | NA |
Mélatonine | NA | 1 mg | NA |
Title | Description |
---|---|
Forme galénique | Capsules T0 HPMC Transparent |
Emballage primaire | PET blanc 75 mL 30 |
Emballage secondaire | NA |
Poids net total | NA |
Characteristic | Int. Ref | Methods | Specifications |
---|---|---|---|
Uniformity of mass | DPQ258EN | ||
Color | DPQ62EN | ||
Aspect | DPQ62EN |
Contaminant | Standards | Specifications |
---|---|---|
Pyrrolizidine alkaloids | Reg. EC 1881/2006 and updates | ≤ 400 ppb |
Benzo(a)pyrene | Reg. EC 1881/2006 and updates | ≤ 10.0 ppb |
Lead | Reg. EC 1881/2006 and updates | ≤ 3.0 ppm |
Mercury | Reg. EC 1881/2006 and updates | ≤ 0.1 ppm |
Pesticides | Eur. Ph.; 2.8.13.-1 | Complies |
Sum of PAH* | Reg. EC 1881/2006 and updates | ≤ 50.0 ppb |
Arsenic | Belgian Reg. of Jan. 7th, 2014 | ≤ 1.0 ppm |
Cadmium | Reg. EC 1881/2006 and updates | ≤ 1.0 ppm |
Microbiology | Standards | Specifications |
---|---|---|
Gram negative bacteria resisting to billiary salts | Eur. Ph.; 5.1.8., §C | 10,000 cfu/g |
E. coli | Eur. Ph.; 5.1.8., §C | None/g |
Staphylococcus aureus | Eur. Ph.; 5.1.4. | None/g |
Yeast and moulds | Eur. Ph.; 5.1.8., §C | 10,000 cfu/g |
Aerobic total count | Eur. Ph.; 5.1.8., §C | 100,000 cfu/g |
Salmonella sp. | Eur. Ph.; 5.1.8., §C | None/25 g |